Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
J Clin Hypertens (Greenwich). 2013 Jan;15(1):14-33. doi: 10.1111/jch.12049. Epub 2012 Dec 18.
In light of the worldwide epidemic of obesity, and in recognition of hypertension as a major factor in the cardiovascular morbidity and mortality associated with obesity, The Obesity Society and the American Society of Hypertension agreed to jointly sponsor a position paper on obesity-related hypertension to be published jointly in the journals of each society. The purpose is to inform the members of both societies, as well as practicing clinicians, with a timely review of the association between obesity and high blood pressure, the risk that this association entails, and the options for rational, evidenced-based treatment. The position paper is divided into six sections plus a summary as follows: pathophysiology, epidemiology and cardiovascular risk, the metabolic syndrome, lifestyle management in prevention and treatment, pharmacologic treatment of hypertension in the obese, and the medical and surgical treatment of obesity in obese hypertensive patients.
鉴于全球肥胖症的流行，并且认识到高血压是肥胖相关心血管发病率和死亡率的主要因素，肥胖学会和美国高血压学会同意共同赞助一份关于肥胖相关高血压的立场文件，该文件将在两个学会的期刊上联合发表。目的是向两个学会的成员以及执业临床医生提供有关肥胖与高血压之间的关联、这种关联所带来的风险以及合理的、基于证据的治疗选择的及时审查。该立场文件分为六个部分加一个总结，如下所示：病理生理学、流行病学和心血管风险、代谢综合征、预防和治疗中的生活方式管理、肥胖患者高血压的药物治疗以及肥胖高血压患者的医疗和手术治疗。
